Insulet Corporation (BIT:1PODD)

Market Cap	14.87B -19.3%
Revenue (ttm)	2.15B +27.1%
Net Income	209.84M -41.5%
EPS	2.94 -39.8%
Shares Out	n/a
PE Ratio	70.88
Forward PE	43.09
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	0
Open	n/a
Previous Close	214.00
Day's Range	n/a
52-Week Range	200.50 - 306.90
Beta	n/a
RSI	41.64
Earnings Date	Feb 18, 2026

About Insulet

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is cont...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2000
• Employees: 3,900
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1PODD

Financial Performance

In 2024, Insulet's revenue was $2.07 billion, an increase of 22.07% compared to the previous year's $1.70 billion. Earnings were $418.30 million, an increase of 102.76%.

Financial numbers in USD